Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycophenolate mofetil in dermatomyositis: is it safe?

J Rowin1, A A Amato, N Deisher

  • 1Department of Neurology and Rehabilitation, University of Illinois, Chicago, IL 60612-7330, USA. rowin@uic.edu

Neurology
|April 26, 2006
PubMed
Summary

Mycophenolate mofetil combined with corticosteroids showed success in treating idiopathic dermatomyositis patients. However, this combination therapy led to a high rate of opportunistic infections, with one fatality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consumption of coffee or caffeine and serum concentration of inflammatory markers: A systematic review.

Critical reviews in food science and nutrition·2017
Same author

Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2016
Same author

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Brain : a journal of neurology·2009
Same author

Inclusion body myositis: old and new concepts.

Journal of neurology, neurosurgery, and psychiatry·2009
Same author

Evaluation and treatment of inflammatory myopathies.

Journal of neurology, neurosurgery, and psychiatry·2009
Same author

Effects of a methanolic fraction of soybean seeds on the transcriptional activity of peroxisome proliferator-activated receptors (PPAR).

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2009

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Idiopathic dermatomyositis is a rare autoimmune disease affecting muscles and skin.
  • Corticosteroids are a standard treatment but have significant side effects.
  • Alternative or adjunctive therapies are needed to improve treatment outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of mycophenolate mofetil in combination with corticosteroids for idiopathic dermatomyositis.
  • To assess the rate of opportunistic infections associated with this combination therapy.

Main Methods:

  • Retrospective case series of 10 patients with idiopathic dermatomyositis.
  • Treatment involved mycophenolate mofetil and corticosteroids.
  • Outcomes included disease relapse and incidence of opportunistic infections.

Related Experiment Videos

Main Results:

  • Six out of 10 patients achieved successful corticosteroid tapering without disease relapse.
  • Three patients developed opportunistic infections.
  • One patient died due to an opportunistic infection.

Conclusions:

  • Combination therapy with mycophenolate mofetil and corticosteroids can be effective in managing idiopathic dermatomyositis.
  • A concerningly high rate of opportunistic infections was observed, necessitating careful monitoring.
  • Further research is warranted to optimize this treatment regimen and mitigate risks.